NRC HEALTH - National Research Ord Shs (NRC)

CUSIP: 637372202

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / National Research Ord Shs
Shares outstanding
22,716,513
Total 13F shares
10,842,597
Share change
+188,193
Total reported value
$184,190,907
Put/Call ratio
58%
Price per share
$16.98
Number of holders
117
Value change
+$3,118,949
Number of buys
41
Number of sells
64

Security key

637372202

Report period

Q1 2026

Institutions

117

Top holders

10

Top shareholders of NRC - NRC HEALTH - National Research Ord Shs (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Common Property Trust
3/4/5 13D/G
10%+ Owner · Beans Patrick E.
46%
from 13D/G
8,609,601
$113,388,445 31 Dec 2024
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
13F 13D/G
Company
12%
from 13D/G
2,657,828
$49,887,447 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
4.4%
from 13D/G
1,005,323
$18,869,912 31 Dec 2025
Trent S. Green
3/4/5
Chief Executive Officer, Director
2.2%
500,000
$6,495,000 01 Jun 2025
Shane R. Harrison
3/4/5
EVP & Chief Financial Officer
0.7%
158,729
$3,415,707 +$98,162 17 Feb 2026
Helen Hrdy
3/4/5
EVP & Chief Operating Officer
0.62%
140,518
$2,478,737 15 Dec 2025
David Burik
3/4/5
EVP, Strategic Insights
0.44%
100,000
$1,877,100 05 Jan 2026
Michael D. Hays
3/4/5
Chairman, Director
0.42%
96,249
$1,735,263 05 Jan 2026
Jason Russell Rau
3/4/5
Executive Vice President
0.26%
60,000
$769,800 12 Mar 2026
Patrick E. Beans
3/4/5
10%+ Owner
0.15%
35,003
$475,673 12 May 2025
Jordan Nicole Freeman
3/4/5
Chief Accounting Officer
0%
771
$9,999 +$10,000 31 Jul 2025
MORGAN STANLEY
13F
Company
4.4%
1,003,709
$18,839,632 31 Dec 2025
13F
VANGUARD GROUP INC
13F
Company
3.7%
831,379
$15,604,984 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.2%
494,504
$9,281,679 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
383,511
$7,199,486 31 Dec 2025
13F
QV Investors Inc.
13F
Company
1.7%
381,310
$7,157,000 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.5%
351,084
$6,589,847 31 Dec 2025
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
1.5%
342,400
$6,426,848 31 Dec 2025
13F
STATE STREET CORP
13F
Company
1.4%
309,609
$5,860,422 31 Dec 2025
13F
Bank of New York Mellon Corp
13F
Company
1.1%
240,977
$4,523,141 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.99%
224,098
$4,206,320 31 Dec 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.95%
216,776
$4,068,891 31 Dec 2025
13F
iA Global Asset Management Inc.
13F
Company
0.83%
187,520
$3,520,000 31 Dec 2025
13F
Willis Investment Counsel
13F
Company
0.81%
183,226
$3,439,152 31 Dec 2025
13F
Northwest & Ethical Investments L.P.
13F
Company
0.57%
129,200
$2,425,084 31 Dec 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.56%
126,261
$2,369,912 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.51%
114,967
$2,157,931 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.48%
109,145
$2,048,651 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.45%
101,756
$1,909,960 31 Dec 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.4%
91,069
$1,709,365 31 Dec 2025
13F
COMERICA BANK
13F
Company
0.4%
89,916
$1,687,723 31 Dec 2025
13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
13F
Company
0.39%
88,207
$1,655,645 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.38%
85,348
$1,601,982 31 Dec 2025
13F
SEI INVESTMENTS CO
13F
Company
0.29%
66,870
$1,255,150 31 Dec 2025
13F
HEARTLAND ADVISORS INC
13F
Company
0.22%
50,000
$938,500 31 Dec 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.22%
49,076
$921,157 31 Dec 2025
13F
BESSEMER GROUP INC
13F
Company
0.21%
47,110
$884,000 31 Dec 2025
13F
Creative Planning
13F
Company
0.2%
45,102
$846,557 31 Dec 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.18%
41,960
$787,673 31 Dec 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.18%
41,862
$785,750 31 Dec 2025
13F
Williams Jones Wealth Management, LLC.
13F
Company
0.18%
41,800
$784,586 31 Dec 2025
13F
ALPS ADVISORS INC
13F
Company
0.18%
40,592
$761,912 31 Dec 2025
13F
Quantinno Capital Management LP
13F
Company
0.17%
38,647
$725,406 31 Dec 2025
13F
US BANCORP \DE\
13F
Company
0.15%
34,518
$647,902 31 Dec 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.13%
30,331
$569,311 31 Dec 2025
13F
UBS Group AG
13F
Company
0.13%
28,464
$534,269 31 Dec 2025
13F
Nuveen, LLC
13F
Company
0.12%
27,337
$513,115 31 Dec 2025
13F
Linden Thomas Advisory Services, LLC
13F
Company
0.12%
27,167
$509,925 31 Dec 2025
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.11%
25,124
$329,125 31 Dec 2025
13F
BARCLAYS PLC
13F
Company
0.11%
24,704
$463,694 31 Dec 2025
13F

Institutional Holders of NRC HEALTH - National Research Ord Shs (NRC) as of Q1 2026

As of 31 Mar 2026, NRC HEALTH - National Research Ord Shs (NRC) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,842,597 shares. The largest 10 holders included KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, QV Investors Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC. This page lists 118 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
114
Q1 2026 holders
117
Holder diff
3
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .